Cidara Therapeutics (NASDAQ:CDTX) Now Covered by Analysts at Citizens Jmp
Investment analysts at Citizens Jmp assumed coverage on shares of Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) in a report issued on Wednesday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $46.00 price target on the biotechnology company’s stock. Citizens Jmp’s price objective indicates a potential upside of 105.72% from the stock’s […]
Investment analysts at Citizens Jmp assumed coverage on shares of Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) in a report issued on Wednesday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $46.00 price target on the biotechnology company’s stock. Citizens Jmp’s price objective indicates a potential upside of 105.72% from the stock’s […]
